JPMorgan Chase & Co. increased its stake in BeOne Medicines Ltd. (06160) by 4,119,720 shares, at a price of approximately HK$219.79 per share.
On August 11, JPMorgan Chase & Co. increased its stake in BeiGene, Ltd. (06160) by 4,119,720 shares, at a price of HKD 219.7851 per share, for a total amount of approximately HKD 905 million.
According to the latest data from the Hong Kong Stock Exchange, on August 11, JPMorgan Chase & Co. increased its stake in BeOne Medicines Ltd. (06160) by 4,119,720 shares, at a price of HK$219.7851 per share, for a total amount of approximately HK$905 million. After the increase, the latest number of shares held is approximately 129 million, accounting for a shareholding ratio of 9.05%.
Related Articles
CITIC SEC: Can the pressure from the midterm elections still trigger a "TACO"?
Broadcom Inc. (AVGO.US) fell 6% overnight: The next hurdle for AI is the cost of financing.
NVIDIA Corporation (NVDA.US) has reduced its guarantee scale for OpenAI data centers by more than 50%.
CITIC SEC: Can the pressure from the midterm elections still trigger a "TACO"?
Broadcom Inc. (AVGO.US) fell 6% overnight: The next hurdle for AI is the cost of financing.
NVIDIA Corporation (NVDA.US) has reduced its guarantee scale for OpenAI data centers by more than 50%.
RECOMMEND
